12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Financial News  |  Other Financial News

Valeant Pharmaceuticals financial update

Valeant said its board authorized a securities repurchase program of up to $1.5...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >